218 related articles for article (PubMed ID: 38619582)
1. [Molecular pathological analysis through the ages].
Walker M; Mayr EM; Koppermann ML; Terron A; Wagner Y; Kling C; Pfarr N
Pathologie (Heidelb); 2024 May; 45(3):173-179. PubMed ID: 38619582
[TBL] [Abstract][Full Text] [Related]
2. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network.
Marchetti A; Barbareschi M; Barberis M; Buglioni S; Buttitta F; Fassan M; Fontanini G; Marchiò C; Papotti M; Pruneri G; Scarpa A; Stanta G; Tallini G; Troncone G; Veronese SM; Truini M; Sapino A
Pathologica; 2021 Aug; 113(4):262-271. PubMed ID: 34463674
[TBL] [Abstract][Full Text] [Related]
5. Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).
Samsom KG; Bosch LJW; Schipper LJ; Roepman P; de Bruijn E; Hoes LR; Riethorst I; Schoenmaker L; van der Kolk LE; Retèl VP; Frederix GWJ; Buffart TE; van der Hoeven JJM; Voest EE; Cuppen E; Monkhorst K; Meijer GA
BMC Med Genomics; 2020 Nov; 13(1):169. PubMed ID: 33167975
[TBL] [Abstract][Full Text] [Related]
6. High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.
Edsjö A; Russnes HG; Lehtiö J; Tamborero D; Hovig E; Stenzinger A; Rosenquist R;
J Intern Med; 2024 Jun; 295(6):785-803. PubMed ID: 38698538
[TBL] [Abstract][Full Text] [Related]
7. Invited review-next-generation sequencing: a modern tool in cytopathology.
Roy-Chowdhuri S; Pisapia P; Salto-Tellez M; Savic S; Nacchio M; de Biase D; Tallini G; Troncone G; Schmitt F
Virchows Arch; 2019 Jul; 475(1):3-11. PubMed ID: 30877381
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
Tafe LJ; Gorlov IP; de Abreu FB; Lefferts JA; Liu X; Pettus JR; Marotti JD; Bloch KJ; Memoli VA; Suriawinata AA; Dragnev KH; Fadul CE; Schwartz GN; Morgan CR; Holderness BM; Peterson JD; Tsongalis GJ; Miller TW; Chamberlin MD
Oncologist; 2015 Sep; 20(9):1011-8. PubMed ID: 26205736
[TBL] [Abstract][Full Text] [Related]
9. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
Shimazawa R; Ikeda M
Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
[TBL] [Abstract][Full Text] [Related]
10. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
12. Molecular Tumor Boards in Clinical Practice.
Luchini C; Lawlor RT; Milella M; Scarpa A
Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
[TBL] [Abstract][Full Text] [Related]
13. Support of a molecular tumour board by an evidence-based decision management system for precision oncology.
Lamping M; Benary M; Leyvraz S; Messerschmidt C; Blanc E; Kessler T; Schütte M; Lenze D; Jöhrens K; Burock S; Klinghammer K; Ochsenreither S; Sers C; Schäfer R; Tinhofer I; Beule D; Klauschen F; Yaspo ML; Keilholz U; Rieke DT
Eur J Cancer; 2020 Mar; 127():41-51. PubMed ID: 31982633
[TBL] [Abstract][Full Text] [Related]
14. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging sequencing-based tools for precision cancer medicine.
Edsjö A; Gisselsson D; Staaf J; Holmquist L; Fioretos T; Cavelier L; Rosenquist R
Mol Aspects Med; 2024 Apr; 96():101250. PubMed ID: 38330674
[TBL] [Abstract][Full Text] [Related]
16. [From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?].
Leichsenring J; Kazdal D; Ploeger C; Allgäuer M; Endris V; Volckmar AL; Neumann O; Kirchner M; Penzel R; Rempel E; Budczies J; Schirmacher P; Fröhling S; Stenzinger A
Pathologe; 2019 May; 40(3):235-242. PubMed ID: 31089797
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology as basis for timely cancer diagnosis and therapy.
Mackinnon AC; Chandrashekar DS; Suster DI
Virchows Arch; 2024 Feb; 484(2):155-168. PubMed ID: 38012424
[TBL] [Abstract][Full Text] [Related]
19. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
Donovan MJ; Cordon-Cardo C
Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing of cancer genomes: lessons learned.
Corrigan AE; Taylor R; Rallis KS
Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
